Scarica l'app Stockscreener
0.8159
2.56%
-0.0214
Dopo l'orario di chiusura:
.83
0.0141
+1.73%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.8373
Aprire:
$0.84
Volume 24 ore:
1.38M
Relative Volume:
1.03
Capitalizzazione di mercato:
$80.49M
Reddito:
-
Utile/perdita netta:
$-93.61M
Rapporto P/E:
-0.3867
EPS:
-2.11
Flusso di cassa netto:
$-71.16M
1 W Prestazione:
-11.32%
1M Prestazione:
+0.11%
6M Prestazione:
-13.43%
1 anno Prestazione:
-47.02%
Intervallo 1D:
$0.8031
$0.85
Intervallo di 1 settimana:
$0.8031
$0.9298
Portata 52W:
$0.561
$1.73
Immunic Inc Stock (IMUX) Company Profile
Nome
Immunic Inc
Settore
Industria
Telefono
(332) 255-9818
Indirizzo
1200 AVENUE OF THE AMERICAS, NEW YORK
Confronta IMUX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.8159 | 83.37M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-29 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-25 | Iniziato | William Blair | Outperform |
| 2024-11-25 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
| 2024-08-27 | Iniziato | B. Riley Securities | Buy |
| 2022-10-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2021-04-15 | Iniziato | Aegis Capital | Buy |
| 2021-03-24 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-10-02 | Iniziato | SVB Leerink | Outperform |
| 2020-08-26 | Iniziato | Piper Sandler | Overweight |
| 2020-08-07 | Ripresa | ROTH Capital | Buy |
| 2020-07-20 | Iniziato | BMO Capital Markets | Outperform |
| 2020-06-05 | Iniziato | Wedbush | Outperform |
| 2020-05-11 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-25 | Iniziato | ROTH Capital | Buy |
| 2019-07-11 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Immunic Inc Borsa (IMUX) Ultime notizie
Price momentum metrics for Immunic Inc. explainedWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Why Immunic Inc. stock could outperform in 2025Treasury Yields & Fast Entry High Yield Stock Tips - newser.com
Why Immunic Inc. stock is favored by top institutionsEarnings Trend Report & Breakout Confirmation Alerts - newser.com
Detecting price anomalies in Immunic Inc. with AIWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com
Using data models to predict Immunic Inc. stock movement2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Immunic Inc.Watch List & Verified Short-Term Plans - newser.com
Will Immunic Inc. stock see PE expansionWeekly Trend Report & Capital Efficiency Focused Strategies - newser.com
Immunic targeting mental and physical challenges facing MS patientsICYMI - Proactive financial news
Can Immunic Inc. recover in the next quarterEarnings Trend Report & Weekly High Conviction Ideas - newser.com
Immunic marks World Mental Health Day, highlighting the mental consequence for MS patients - Proactive financial news
Why Immunic Inc. (10VA) stock fits value portfolios2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Why Immunic Inc. (10VA) stock benefits from AI revolutionProduct Launch & Verified Momentum Stock Alerts - newser.com
Comparing Immunic Inc. in custom built stock radarsJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - newser.com
Immunic (NASDAQ:IMUX) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Immunic Presents Promising Phase 2 Trial Results - MSN
Immunic receives notice of allowance for vidofludimus calcium patent - MSN
Is Immunic Inc. (10VA) stock positioned for secular growthQuarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Chart overlay techniques for tracking Immunic Inc.Profit Target & Risk Controlled Stock Alerts - newser.com
Risk adjusted return profile for Immunic Inc. analyzed2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Using data tools to time your Immunic Inc. exitEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Is Immunic Inc. stock ready for a breakout2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
How to read the order book for Immunic Inc.Earnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Can Immunic Inc. stock sustain institutional interestGDP Growth & Weekly Top Gainers Trade List - newser.com
Immunic Inc Azioni (IMUX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immunic Inc Azioni (IMUX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
| Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):